3
ICAP

may, 2018

HVTN 704/HPTN 085: Antibody Mediated Prevention (Amp Study)

Project Details

HVTN 704/HPTN 085 is a five-year study testing the safety, tolerability, and prevention benefit of a manufactured antibody (VRC01) against HIV. The study aims to recruit about 2,700 participants from sites in the U.S. and South America. The Bronx Prevention Center will serve as one of the U.S. sites and will recruit HIV-uninfected men and transgender women who have sex with men. (funded by the NIH)